Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas

Clinical trial NCT00766753 · COMPLETED

Trial details

NCT number: NCT00766753
Sponsor: Frank Lieberman
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Glioma

Start date: 2006-12-01
Primary completion: 2009-09-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.